About Communications       Author's Guide       Reviewers       Editorial Members       Archive
Volume 8
Volume 7
Volume 6
Volume 5
Volume 4
Volume 3
Volume 2
Volume 1
AASCIT Communications | Volume 3, Issue 1 | Feb. 15, 2016 online | Page:56-63
Towards More Effective Dialysis Treatment in Patients with Chronic Kidney Disease: Hypothetical Model of Dialyzer with Double Capillary Walls
Plasma dialysis, which involves separation of blood cells from the plasma before the dialyzer, allowing only for the passage of plasma through the dialyzer canal. The aim of this study was to suggest novel model of high efficacy plasma dialysis as hemodialysis alternative. Electron microscopy imaging of the capillary lumens following an investigation plasma dialysis and hemodialysis were performed. Full blood clearance index was calculated, basing on the percent reduction of creatinine level before and after the dialysis both for the typical hemodialysis and plasma dialysis. Visualization of the plasma dialysis procedure indication decrease in the number of attached blood cells of compared to the hemodialysis. Creatinine clearance index ranged 79-86% for the hemodialysis and decreased over time during the procedure, while for plasma dialysis ranged from 94 to 95%. Also, no decreasing trend in procedure efficacy over time was found. Based on the experimental data two models for dialyzers were designed: rotary dialyzer and dialyzer with double capillary walls. Plasma dialysis may allow for the improved plasma clearance with estimated about 20% higher efficacy compared to the hemodialysis based systems, be useful in the setting of relatively low blood flow (for example 100- 150 ml/min) and may reduce duration and frequency of dialysis procedures.
Krzysztof Dziewanowski, Centre of Nephrology and Renal Transplantation, Regional Hospital, Szczecin, Poland.
Radosław Drozd, Centre of Nephrology and Renal Transplantation, Regional Hospital, Szczecin, Poland.
Miłosz Parczewski, Department of Infectious Diseases, Pomeranian Medical University, Szczecin, Poland.
Stanisław Mazurkiewicz, University of Technology, Faculty of Mechanical Engineering, Cracow, Poland.
Plasma Dialysis, Chronic Renal Failure, Dialyzers, Novel Systems
Davenport A. Early start renal replacement therapy for acute kidney injury-universal panacea or another case of over medicalization? Hemodial Int. 2015; 19: 12351.
Shah SV, Shukla AM, Bose C, Basnakian AG, Rajapurkar M. Recent advances in understanding the pathogenesis of atherosclerosis in ckd patients. J Ren Nutr. 2015; 25: 205-208.
Schneider AG, Bagshaw SM. Effects of renal replacement therapy on renal recovery after acute kidney injury. Nephron Clin Pract. 2014; 127: 35-41.
Jablonski KL, Chonchol M. Recent advances in the management of hemodialysis patients: A focus on cardiovascular disease. F1000Prime Rep. 1000; 6: 6-72.
Roy-Chaudhury P, Kruska L. Future directions for vascular access for hemodialysis. Semin Dial. 2015; 28: 107-113.
Fissell R, Hakim RM. Improving outcomes by changing hemodialysis practice patterns. Curr Opin Nephrol Hypertens. 2013; 22: 675-680.
Jacobson H, Klahr S, Striker G. Principles and practice of nephrology. Mosby-Year Book (January 1995). 1995: 713-721.
Kale-Pradhan PB, Woo MH. A review of the effects of plasmapheresis on drug clearance. Pharmacotherapy. 1997; 17: 684-695.
Nenov D, Metodiev K. Combined treatment of immune nephropathies with plasmapheresis and immunosuppressants. Biomater Artif Cells Artif Organs. 1988; 16: 991-997.
Weinstein R. Is there a scientific rationale for therapeutic plasma exchange or intravenous immune globulin in the treatment of acute guillain-barré syndrome? J Clin Apher. 1995; 10: 150-157.
Weinstein R. Prevention of citrate reactions during therapeutic plasma exchange by constant infusion of calcium gluconate with the return fluid. J Clin Apher. 1996; 11: 204-210.
Carter CE, Benador NM. Therapeutic plasma exchange for the treatment of pediatric renal diseases in 2013. Pediatr Nephrol. 2014; 29: 35-50.
Kaplan AA. Plasma exchange in renal disease. Seminars in Dialysis. 1996; 9: 61-70.
Madore F. Plasmapheresis. Technical aspects and indications. Crit Care Clin. 2002; 18: 375-392.
Orlandini GC, Margaria R. Evaluation of the efficiency of a new hollow fiber plasmapheresis filter. Int J Artif Organs. 1983; 6 Suppl 1: 103-106.
Kaplan AA. General principles of therapeutic plasma exchange. Seminars in Dialysis. 1995; 8: 294-298.
Kaplan AA. Plasma exchange for non-renal indications. Seminars in Dialysis. 1996; 9: 265-275.
Tan HK, Hart G. Plasma filtration. Ann Acad Med Singapore. 2005; 34: 615-624.
Madore F, Lazarus JM, Brady HR. Therapeutic plasma exchange in renal diseases. J Am Soc Nephrol. 1996; 7: 367-386.
Mokrzycki MH, Kaplan AA. Therapeutic plasma exchange: Complications and management. Am J Kidney Dis. 1994; 23: 817-827.
Hajime N, Michiko A, Atsunori K, et al. A case report of efficiency of double filtration plasmapheresis in treatment of goodpasture's syndrome. Ther Apher Dial. 2009; 13: 373-377.
Dziewanowski K, Drozd R. Plasmadialysis as alternative method to improve degree of the dialysis in patients with chronic renal failure (in polish). Forum Nefrol. 2013; 6: 150-154.
Arcticle History
Submitted: Dec. 15, 2015
Accepted: Jan. 6, 2016
Published: Feb. 15, 2016
The American Association for Science and Technology (AASCIT) is a not-for-profit association
of scientists from all over the world dedicated to advancing the knowledge of science and technology and its related disciplines, fostering the interchange of ideas and information among investigators.
©Copyright 2013 -- 2019 American Association for Science and Technology. All Rights Reserved.